Clinical decisions associated with positron emission tomography in a prospective cohort of patients with suspected or known cancer at one United States center

Journal of Clinical Oncology

Volumn 22, Issue 20, 2004, Pages 4147-4156

  Hillner, Bruce E ^a   Tunuguntla, Renuka ^a   Fratkin, Melvin ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ARTICLE; CANCER; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; DECISION MAKING; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; LYMPHOMA; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; TUMOR BIOPSY; UNITED STATES; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FEMALE; HEALTH PERSONNEL ATTITUDE; MALE; METASTASIS; MIDDLE AGED; NEOPLASM; PATIENT CARE; PROBABILITY; SCINTISCANNING;

ATTITUDE OF HEALTH PERSONNEL; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; PATIENT CARE MANAGEMENT; PROBABILITY; PROSPECTIVE STUDIES; QUESTIONNAIRES; TOMOGRAPHY, EMISSION-COMPUTED; UNITED STATES;

EID: 7044272502     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.12.115     Document Type: Article

References (21)

1. Gould M, Maclean C, Kuschner W, et al: Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: A meta-analysis. JAMA 285:914-924, 2001
2. Huebner R, Park K, Shepherd J, et al: A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41:1177-1189, 2000
3. Toloza EM, Harpole L, McCrory DC: Noninvasive staging of non-small cell lung cancer: A review of the current evidence. Chest 123:137S-146S, 2003
4. Kinkel K, Lu Y, Both M, et al: Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): A meta-analysis. Radiology 224:748-756, 2002
5. Naumann R, Vaic A, Beuthien-Baumann B, et al: Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma. Br J Haematol 115:793-800, 2001
6. Spaepen K, Stroobants S, Dupont P, et al: Early restaging positron emission tomography with (18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 13:1356-1363, 2002
7. Pieterman R, van Putten J, Meuzelaar J, et al: Preoperative staging of non-small-cell lung cancer with positron-emission tomography. N Engl J Med 343:254-261, 2000
8. van Tinteren H, Hoekstra O, Smit B, et al: Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: The PLUS multicentre randomised trial. Lancet 359:1388-1393, 2002
9. Kalff V, Hicks R, MacManus M, et al: Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: A prospective study. J Clin Oncol 19:111-118, 2001
10. Herder G, Van Tinteren H, Comans E, et al: Prospective use of serial questionnaires to evaluate the therapeutic efficacy of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) in suspected lung cancer. Thorax 58:47-51, 2003
11. Yap C, Seltzer M, Schiepers C, et al: Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: The referring physician's perspective. J Nucl Med 42:1334-1337, 2001
12. Meta J, Seltzer M, Schiepers C, et al: Impact of 18F-FDG PET on managing patients with colorectal cancer: The referring physician's perspective. J Nucl Med 42:586-590, 2001
13. Schoder H, Meta J, Yap C, et al: Effect of whole-body 18F-FDG PET imaging on clinical staging and management of patients with malignant lymphoma. J Nucl Med 42:1139-1143, 2001
14. Landis J, Koch G: The measurement of observer agreement for categorical data. Biometrics 33:159-174, 1977
15. Laird NM, Ware JH: Random-effects models for longitudinal data. Biometrics 38:963-974, 1982
16. FDG Positron Emission Tomography (CAG-00065) Decision Memorandum: National Medicare Coverage Decision on FDG PET. Federal Register December 15, 2000
17. Deyo R, Jarvik J: New diagnostic tests: Breakthrough approaches or expensive add-ons? Ann Intern Med 139:950-951, 2003
18. Black ER, Bordley DR, Tape TG, et al: Diagnostic Strategies for Common Medical Problems (ed 2). Philadelphia, PA, American College of Physicians, 1999
19. Lamont EB, Christakis NA: Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134:1096-1105, 2001
20. Detterbeck F, Falen S, Rivera M, et al: Seeking a home for a PET, Part 2: Defining the appropriate place for positron emission tomography imaging in the staging of patients with suspected lung cancer. Chest 125:2300-2308, 2004
21. Detterbeck F, Falen S, Rivera M, et al: Seeking a home for a PET, Part 1: Defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses. Chest 125:2294-2299, 2004